Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human N-Acetyltransferase 1 and 2 Differ in Affinity Towards Acetyl-Coenzyme A Cofactor and N-Hydroxy-Arylamine Carcinogens. | Front Pharmacol | 2022 | 35281898 | PubTator, text mining | PubMed |
| A review on the genetic polymorphisms and susceptibility of cancer patients in Bangladesh. | Mol Biol Rep | 2022 | 35277785 | PubTator, text mining | PubMed |
| The association between meat and fish intake by preparation methods and breast cancer in the Carolina Breast Cancer Study (CBCS). | Breast Cancer Res Treat | 2022 | 35275284 | PubTator, text mining | PubMed |
| Trophoblast Differentiation Affects Crucial Nutritive Functions of Placental Membrane Transporters. | Front Cell Dev Biol | 2022 | 35273963 | PubTator, text mining | PubMed |
560G>A (rs4986782) (R187Q) Single Nucleotide Polymorphism in Arylamine N-Acetyltransferase 1 Increases Affinity for the Aromatic Amine Carcinogens 4-Aminobiphenyl and N-Hydroxy-4-Aminobiphenyl: Implications for Cancer Risk Assessment. | Front Pharmacol | 2022 | 35273499 | PubTator, text mining | PubMed |
| Pharmacogenomics Testing in Phase I Oncology Clinical Trials: Constructive Criticism Is Warranted. | Cancers (Basel) | 2022 | 35267440 | PubTator, text mining | PubMed |
| Advances in Key Drug Target Identification and New Drug Development for Tuberculosis. | Biomed Res Int | 2022 | 35252448 | PubTator, text mining | PubMed |
| The glucose-lowering effect of low-dose diacerein and its responsiveness metabolic markers in uncontrolled diabetes. | BMC Res Notes | 2022 | 35246243 | PubTator, text mining | PubMed |
| Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy. | Int J Mol Sci | 2022 | 35216481 | PubTator, text mining | PubMed |
| Whole Genome Analysis of 335 New Bacterial Species from Human Microbiota Reveals a Huge Reservoir of Transferable Antibiotic Resistance Determinants. | Int J Mol Sci | 2022 | 35216256 | PubTator, text mining | PubMed |
| SWAAT Bioinformatics Workflow for Protein Structure-Based Annotation of ADME Gene Variants. | J Pers Med | 2022 | 35207751 | PubTator, text mining | PubMed |
| Thyroid Cancer Diagnostics Related to Occupational and Environmental Risk Factors: An Integrated Risk Assessment Approach. | Diagnostics (Basel) | 2022 | 35204408 | PubTator, text mining | PubMed |
| Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson's Disease Pathogenesis: A Narrative Review. | Brain Sci | 2022 | 35203939 | PubTator, text mining | PubMed |
| Gene Expression Analysis of Aggressive Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical Stage T1N0M0 to Identify Potential Prognostic and Therapeutic Biomarkers. | Biomedicines | 2022 | 35203530 | PubTator, text mining | PubMed |
| Genotypic and phenotypic landscapes of 51 pharmacogenes derived from whole-genome sequencing in a Thai population. | PLoS One | 2022 | 35176049 | PubTator, text mining | PubMed |
| Deep Resequencing of 9 Candidate Genes Identifies a Role for ARAP1 and IGF2BP2 in Modulating Insulin Secretion Adjusted for Insulin Resistance in Obese Southern Europeans. | Int J Mol Sci | 2022 | 35163144 | PubTator, text mining | PubMed |
| Arylamine N-Acetyltransferase 1 Activity is Regulated by the Protein Acetylation Status. | Front Pharmacol | 2022 | 35153780 | PubTator, text mining | PubMed |
| Local anesthetics for the Nephrologist. | Clin Kidney J | 2022 | 35145634 | PubTator, text mining | PubMed |
| The role of environmental exposures and gene-environment interactions in the etiology of systemic lupus erythematous. | J Intern Med | 2022 | 35143075 | PubTator, text mining | PubMed |
| Aberrant epigenetic and transcriptional events associated with breast cancer risk. | Clin Epigenetics | 2022 | 35139887 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=26